Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer. Indian J Case Reports [Internet]. 2024 Sep. 30 [cited 2026 Aug. 19];10(10):322-4. Available from: https://mansapublishers.com/ijcr/article/view/4727